eFuture (EFUT) Files 2010 Annual Report on Form 20-F

BEIJING, June 28, 2011 (GLOBE NEWSWIRE) — eFuture Information Technology Inc. (Nasdaq:EFUT) (the “Company” or “eFuture”), a leading provider of software and services in China’s rapidly growing retail and consumer goods industries, today announced that the Company filed its annual report for the year ended December 31, 2010 on Form 20-F with the United States Securities and Exchange Commission (the “SEC”) on June 28, 2011.

The Form 20-F is available on the Company’s website via the following link: http://ir.e-future.com.cn/phoenix.zhtml?c=204768&p=irol-sec and is also available on the SEC website at http://www.sec.gov.

About eFuture Information Technology Inc.

eFuture Information Technology Inc. (Nasdaq:EFUT) is a leading provider of software and services in China’s rapidly growing retail and consumer goods industries. eFuture provides integrated software and services to manufacturers, distributors, wholesalers, logistics companies and retailers in China’s front-end supply chain (from factory to consumer) market, especially in the retail and fast moving consumer goods industries. For more information about eFuture, please visit http://www.e-future.com.cn.

CONTACT: Investor Contact:
         Troe Wen, Company Secretary
         eFuture Information Technology Inc.
         +86 10 5293 7699
         ir@e-future.com.cn

         Investor Relations (HK):
         Mahmoud Siddig
         Taylor Rafferty
         +852 3196 3712
         eFuture@Taylor-Rafferty.com

         Investor Relations (US):
         Kelly Gawlik
         Taylor Rafferty
         +1 212 889 4350
         eFuture@Taylor-Rafferty.com

SGOCO Group, Ltd. (SGOC) to Report 2011 First Quarter Results on Tuesday, June 28th

Jun. 28, 2011 (Business Wire) — SGOCO Group, Ltd. (NASDAQ: SGOC), (the “Company” or “SGOCO”), a company focused on building its own brands and retail distribution network in the Chinese flat panel display market, including monitors, TVs, and application specific products, today announced that it will issue its financial results for the first quarter ended March 31, 2011 on Tuesday, June 28, 2011 after the close of the stock market. SGOCO’s management will host a conference call at 10:00 am ET on Wednesday, June 29, 2011 to discuss these results as well as recent corporate developments. After opening remarks, there will be a question and answer period. Interested parties may participate in the call by dialing (201) 493-6749. Please call in 10 minutes before the conference is scheduled to begin and ask for the SGOCO call. Questions may be asked during the live call, or alternatively, you may e-mail questions in advance to lcati@equityny.com.

The conference call will also be broadcast live over the Internet. To listen to the live call, please go to www.sgocogroup.com, click on the Investor Relations section, then to the Event Calendar where the conference call is posted. Please go to the website 15 minutes early to download and install any necessary audio software. If you are unable to listen live, the conference call will be archived and can be accessed for approximately 90 days. We suggest listeners use Microsoft Explorer as their browser.

About SGOCO Group, Ltd.

SGOCO Group, Ltd. is focused on building its own brands and retail distribution network in the flat panel display market, including monitors, TVs, and application specific products. With a network of hundreds of SGOCO Image branded retail partners, the Company is rapidly expanding in China’s tier 3 and tier 4 cities. By providing international standard quality products at competitive prices, the Company believes it is well positioned to take advantage of the emergence of China’s new consumer culture. For more information about SGOCO, please visit http://www.sgocogroup.com.

SGOCO Group, Ltd. (China)

Bill Krolicki, + 86-10-8587-0170

VP of Finance

bill@sgoco.com

or

The Equity Group Inc. (US)

Lena Cati, 212-836-9611

lcati@equityny.com

or

Linda Latman, 212-836-9609

llatman@equityny.com

Preferred Apartment Communities, Inc. (APTS) Confirms Quarterly Dividend

Frontier Airlines (RJET) Launches New Seasonal Service Between Branson and Both Austin and Phoenix

Jun. 27, 2011 (Business Wire) — Frontier Airlines, a wholly owned subsidiary of Republic Airways Holdings, Inc. (NASDAQ:RJET), today announced plans to add nonstop seasonal service between Branson, Mo. (BKG) and both Austin, Texas (AUS) and Phoenix, Ariz. (PHX) to its route map. The carrier will be the only airline offering nonstop service on these new routes.

Branson-Austin service will operate Monday, Wednesday and Friday from Sept. 16 through Dec. 14, 2011. Branson-Phoenix service will operate Saturdays from Sept. 17 through Dec. 10, 2011. Austin service will be provided on 50-seat Embraer 145 aircraft; Phoenix service will operate on 138-seat Airbus 319 aircraft, which feature available STRETCH seating with 5 inches of additional legroom and 24 channels of DirecTV^® at every seat.

“Branson is a great family-friendly entertainment destination that our customers have really responded to,” said Daniel Shurz, vice president of strategy and planning for Frontier. “We’re delighted to have found the opportunity to add more routes into Branson and deliver our high-quality, affordable service.” Frontier already serves Denver and Milwaukee nonstop from Branson.

“Frontier’s new nonstop service to Austin and Phoenix is very exciting,” stated Jeff Bourk, executive director at the Branson Airport. “Frontier now offers four nonstop cities and we are pleased they continue the Branson Airport tradition of convenient air travel and low fares.”

Introductory fares begin at $89 each way for the new Branson-Austin nonstop route and $105 each way for the new Branson-Phoenix nonstop route. The fares are available at FrontierAirlines.com/introfares through Sept. 17, 2011 for travel through Oct. 31, 2011.

Following are schedules for the new routes:

For more information or to purchase a Frontier flight, visit FrontierAirlines.com.

Terms and Conditions for Branson-Austin and Branson-Phoenix Nonstop Introductory Fares

Tickets must be purchased by 11:59 p.m. Eastern time, September 17, 2011. Fares shown are each way for travel through October 31, 2011. A 14-day advance purchase is required. Seats are limited at these fares and certain flights and/or days of travel may be unavailable, especially during busy travel periods. Tickets are nonrefundable and nontransferable, but may be reissued for up to a $50 change fee (depending on the fare type purchased) as well as a possible fare increase to a non-promotional fare type. Previously purchased tickets may not be exchanged for these special fare tickets. Flight segment(s) must be cancelled prior to scheduled departure time or the ticket(s) and all monies will be forfeited.

Fares shown reflect purchase at FrontierAirlines.com. Tickets purchased on Frontier’s website must be paid for at the time the reservation is made. Depending on the fare type purchased, a $20 fee may be charged each way for the first and for the second pieces of checked baggage. Fares do not include passenger facility fees of up to $9 each way, the September 11th Security Fee of up to $5 each way, or fees of $3.70 per segment (one takeoff/one landing), and are subject to change without notice.

Some markets do not offer daily connections. Due to schedule changes, markets may not connect throughout the valid travel period. Branson-Austin nonstop seasonal service operates on Monday, Wednesday and Friday from September 16 through December 14, 2011. Branson-Phoenix nonstop seasonal service operates on Saturday from September 17 through December 10, 2011.

Flights are operated by Frontier Airlines, Republic Airlines or Chautauqua Airlines. Fares and schedules are subject to change without notice. Other restrictions may apply.

About Frontier Airlines

Frontier Airlines is a wholly owned subsidiary of Republic Airways Holdings, Inc. (NASDAQ: RJET), an airline holding company that also owns Chautauqua Airlines, Republic Airlines and Shuttle America. Currently in its 17^th year of operations, Frontier employs more than 5,500 aviation professionals and operates more than 500 daily flights from its hubs at Denver International Airport, Milwaukee’s General Mitchell International Airport and Kansas City International Airport. Frontier offers service to more than 80 destinations in the United States, Mexico and Costa Rica.

For in-depth information on Frontier Airlines and to book tickets, visit FrontierAirlines.com.

Frontier Airlines

720-374-4560

media@flyfrontier.com

GSV Capital (GSVC) Invests in Facebook

WOODSIDE, Calif., June 27, 2011 (GLOBE NEWSWIRE) — GSV Capital Corp. (Nasdaq:GSVC) announced that it has acquired 225,000 shares in social-networking company Facebook at an average price of $29.28 per share. The investment of $6,587,500 represents approximately 15% of GSV’s total portfolio.

“Facebook is a one-of-a-kind business which has created enormous network effects. With over 650 million people on its platform, or approximately 1/10 of the world’s population, Facebook has established itself as a next generation social communications platform,” said Michael T. Moe, GSV Capital’s CEO and founder.

GSV Capital’s mission is to identify and invest in the premier VC backed private companies in the marketplace today – at attractive valuations.

“GSV leveraged its network to quickly execute the transaction, entering the agreement to purchase shares of Facebook shortly after the close of our company’s initial public offering. This is a true testament to the strength of our team and a great example of how we intend to quickly seize opportunities on behalf of our investors,” Moe added.

This purchase of Facebook shares was subject to certain closing conditions, including a 30-day “Right of First Refusal” or ROFR, expiration.

GSV is presently in the final stages with a handful of private company investments that it anticipates acquiring within the next 30 days, subject to applicable closing conditions.

About GSV Capital Corp.

GSV Capital Corp. (Nasdaq:GSVC) is a publicly traded investment fund that gives individual investors access to high growth, venture backed private companies. GSV Capital is a closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. GSV is headquartered in Woodside, CA. For more information please visit http://gsvcap.com/

The GSV Capital Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=9556

Forward-Looking Statements

Statements included herein may constitute “forward-looking statements,” which relate to future events or our future performance or financial condition. These statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in our filings with the Securities and Exchange Commission. GSV Capital Corp. undertakes no duty to update any forward-looking statements made herein.

CONTACT: Investors:
         Alex Wellins
         (415) 217-5861
         alex@blueshirtgroup.com

         Media:
         Kim Hughes
         (415) 489-2188
         kim@blueshirtgroup.com

Servidyne (SERV) Agrees to Be Acquired by Scientific Conservation, Inc.

Jun. 27, 2011 (Business Wire) — SERVIDYNE, INC. (NASDAQ: SERV), an energy efficiency and demand response company, today announced that it has entered into an agreement to be acquired by Scientific Conservation Inc. (SCI) for $3.50 per share in an all-cash transaction.

The acquisition is subject to Servidyne, Inc. shareholder approvals and other customary closing conditions, and is currently expected to be completed in Servidyne’s second fiscal quarter ending October 31, 2011. Following the sale, Servidyne will no longer be a publicly-traded company, and its shares will cease to be traded on the NASDAQ Global Market.

“We are pleased that this agreement recognizes the value of Servidyne’s expertise, relationships, technologies and solutions, while providing our stockholders with an attractive cash premium for their investment,” said Alan R. Abrams, Chairman and CEO of Servidyne.

Servidyne and SCI have industry-leading engineering and technology expertise in energy efficiency, demand response, building maintenance management and building controls. The acquisition is expected to strengthen and enhance customer value.

Servidyne’s financial advisor is Ladenburg Thalmann & Co. Inc. and its legal advisor is Kilpatrick Townsend & Stockton LLP. SCI’s financial advisor is Roth Capital Partners, LLC and its legal advisor is Cooley LLP.

About Servidyne

Servidyne, Inc. is headquartered in Atlanta, Georgia, and operates globally through its wholly–owned subsidiaries. The Company provides comprehensive energy efficiency and demand response solutions, sustainability programs, and other products and services that significantly enhance the operating and financial performance of existing buildings. Servidyne enables its customers to cut energy consumption and realize immediate cost savings across their portfolios, while reducing greenhouse gas emissions and improving the comfort and satisfaction of their buildings’ occupants. The Company serves a broad range of markets in the United States and internationally, including owners and operators of corporate, commercial office, hospitality, gaming, retail, light industrial, distribution, healthcare, government, multi-family and education facilities, as well as energy services companies and public and investor-owned utilities. For more information, please visit www.servidyne.com or call 770-933-4200.

About Scientific Conservation Inc.

Scientific Conservation Inc., (SCI) a leading provider of energy efficiency solutions via predictive diagnostics and analytics for the $5 billion commercial building market. The company’s suite of energy management solutions uses the industry’s first software-as-a-service (SaaS) platform to help reduce annual energy spending by comparing predicted energy and system efficiencies against real-time operation. The company’s headquarters are in San Francisco, CA, with its technology center in Atlanta, GA. For more information, visit www.scientificconservation.com.

ADDITIONAL INFORMATION ON THE MERGER AND WHERE TO FIND IT

This press release does not constitute a solicitation of any vote or approval. In connection with the proposed merger, Servidyne, Inc. will file a proxy statement with the SEC, and deliver the definitive proxy statement to its shareholders. Servidyne shareholders are urged to read the proxy statement when it becomes available, as well as other documents filed with the SEC, because they will contain important information about the merger. The proxy statement and other documents Servidyne files with the SEC will be available free of charge at the SEC’s web site (www.sec.gov) or from Servidyne’s website (www.servidyne.com) under the tab “Investor Relations” and then under the heading “All SEC Filings”. Free copies of Servidyne’s filings also may be obtained by directing a request to investorrelations@servidyne.com.

Servidyne and its directors and executive officers may be deemed, under SEC rules, to be participants in the solicitation of proxies from Servidyne’s shareholders with respect to the proposed transaction. Information about the directors and executive officers of Servidyne is included in its definitive proxy statement for its 2010 annual meeting of shareholders filed with the SEC on July 28, 2010. More detailed information regarding the identity of potential participants, and their direct or indirect interests, by securities holdings or otherwise, will be set forth in the proxy statement and other documents to be filed with the SEC in connection with the proposed merger.

CAUTIONARY NOTE ABOUT FORWARD-LOOKING STATEMENTS

Certain statements contained or incorporated by reference in this press release, including without limitation, statements containing the words “believe,” “anticipate,” “estimate,” “expect,” “plan,” “project,” “forecast,” “should,” and words of similar import, are forward-looking statements within the meaning of the federal securities laws. Forward-looking statements included in this press release include, without limitation, statements regarding the expected closing of the proposed transaction, which projections are subject to the risk of nonsatisfaction of closing conditions, among other risks. Forward-looking statements involve known and unknown risks, uncertainties, and other matters which may cause the actual results, performance, or achievements of Servidyne to be materially different from any future results, performance, or uncertainties expressed or implied by such forward-looking statements. Factors affecting forward-looking statements in this release include, without limitation, the factors identified under the caption “Risk Factors” in the Company’s Current Report on Form 8-K filed with the SEC on June 2, 2011, as such factors may be updated from time to time by subsequent Servidyne SEC reports. Servidyne does not undertake to update these forward-looking statements.

Pietryla Enterprises/Public Relations

Christine Pietryla, (312) 612-0283

cpietryla@pietryla.com

Scorpex, Inc. (SRPX)

Scorpex, Inc. is focused on becoming a leader of hazardous and toxic waste disposal in the Baja Mexico/California region where demand for waste management exceeds capacity. To date, the company has constructed a 10,000 square foot storage facility, water reservoir and septic system, sprinkler system, and security fence and is in the process of developing other necessary infrastructure on its 26-acre site.

Joseph Caywood is the founder of Scorpex International and has developed the project for several years. His efforts have included overseeing construction, land acquisition, site development, permit applications, governmental relations, and submitting focused studies and reports by experts in this industry. As a result of his efforts, Scorpex will have the only industrial waste processing facility of its kind in Baja Mexico.

The Mexican economy has experienced significant growth in the manufacturing sector over the past several years. This growth has been fuelled by the NAFTA treaty and investments from foreign national companies. The growth of both new and existing industries has dramatically increased the need for the disposal of industrial waste throughout Mexico, especially in the Baja California region.

The company’s future expansion plans include constructing other strategically placed, specially designed, storage, recycling and disposal facilities in various locations throughout Mexico. All facilities will be designed specifically for the purpose of processing the nation’s growing industrial waste, including materials that are classified as industrial, toxic, and hazardous.

Key Investment Highlights

• Burgeoning Opportunities in Rapidly Growing Sector
• Creating a Cleaner Environment for Surrounding Communities
• Developing the Only Processing Facility of its Kind in Baja Mexico
• Solid Business Strategy to Capitalize on Nationwide Demand

Merriman Capital (MERR) Announces Sponsorship of Radient Pharmaceuticals Corp (RXPC) on OTCQX

SeraCare (SRLS) Acknowledges Receipt of Unsolicited Proposal from MSMB Capital

Drilling Recommences at Almaden’s (AAU) Ixtaca Project, Mexico

VANCOUVER, BRITISH COLUMBIA — (Marketwire) — 02/07/11 — Almaden Minerals Ltd. (“Almaden” or “the Company”) (TSX: AMM)(NYSE Amex: AAU) is pleased to announce that a two drill exploration and definition program is now underway at the Company’s wholly owned Ixtaca gold-silver project located in Puebla State, Mexico.

“Our goal for 2011 at Almaden is to outline the potential of the Ixtaca Zone through a minimum $C2MM drill program,” says Morgan Poliquin, Almaden President and CEO. “Drilling in 2011 is designed to explore the size potential of the Ixtaca zone, discovered by the Company in 2010. Drilling is also planned on other targets on the property that have the potential for vein mineralisation similar to that of the Ixtaca Zone.”

The Company plans to build on the exploration success of last year, during which the Ixtaca drilling discovery was made. Since the discovery hole announced in August 2010, the Company completed a total of 14 holes in 2010, all of which intersected mineralisation. The Ixtaca gold-silver epithermal vein system has now been traced over 300 meters along strike. Highlights of the drilling to date include high grade intersections of 4.10 m of 26 g/t Au, 936 g/t Ag (hole TU-10-1), 3.17 m of 10.5 g/t Au, 586 g/t Ag (hole TU-10-12) and 1.77 m of 49 g/t Au, 1392 g/t Ag (hole TU-10-11) as well as broad intersections such as 136.92 m of 1.5 g/t Au, 36 g/t Ag (hole TU-10-10), 45.01 m of 2.4 g/t Au, 157 g/t Ag (hole TU-10-12), 203.65 m of 1.0 g/t Au, 44 g/t Ag (Hole TU-10-11) and 126.22 m of 0.9 g/t Au, 62 g/t Ag (Hole TU-10-6). True widths cannot be calculated with confidence at this time. The Company will advance this 100% owned project with the drilling program announced today which will be expanded as necessary. This program will be funded and managed by the Company.

ABOUT ALMADEN

Almaden is a well-financed (no debt, approximately $C24 MM in working capital) mineral exploration company working in North America. The company has assembled mineral exploration projects, including Tuligtic, through its grass roots exploration efforts. While the properties are largely at early stages of development they represent exciting opportunities for the discovery of significant gold, silver and copper deposits as evidenced at Ixtaca. Currently six projects (Caldera, Caballo Blanco, Tropico, Nicoamen River and Matehuapil and Merit), are optioned to separate third parties who each have the right to acquire an interest in the respective project from Almaden through making certain payments and exploration expenditures. Four further projects are held in joint ventures. Almaden also holds a 2% NSR interest in 11 projects. Almaden’s business model is to find and acquire mineral properties and develop them by seeking option agreements with others who can acquire an interest in a project by making payments and exploration expenditures. Through this means the company has been able to expose its shareholders to discovery and capital gain without the funding and consequent share dilution that would be required if the company were to have developed these projects without a partner. The company intends to expand this business model, described by some as prospect generation, by more aggressively exploring several of its projects including the Ixtaca Zone.

Morgan J. Poliquin, Ph. D., P. Eng., the President and CEO of Almaden, and a qualified person (“QP”) under the meaning of National Instrument 43-101, reviewed the technical information in this news release. The analyses reported were carried out at ALS Chemex Laboratories of North Vancouver using industry standard aqua regia, ICP and fire assay techniques. Blanks, field duplicates and certified standards were inserted into the sample stream as part of Almaden’s quality assurance and control program which complies with National Instrument 43-101 requirements. Gold equivalent (“AuEq” or “Gold Eq.”) and silver equivalent (“AgEq” or “Silver Eq.”) values were calculated using silver to gold ratios of 50 to 1. Intervals that returned assays below detection were assigned zero values. Metallurgical recoveries and net smelter returns are assumed to be 100% for these calculations. Registered geologist Jim Lunbeck, a QP under the meaning of NI 43-101, will be the QP and project manager of Almaden’s 2011 Ixtaca program.

On Behalf of the Board of Directors

Morgan J. Poliquin, Ph.D., P.Eng., President, CEO and Director

Almaden Minerals Ltd.

Statements contained in this news release that are not historical facts are forward looking statements as that term is defined in the private securities litigation reform act of 1995. Such forward -looking statements are subject to risks and uncertainties which could cause actual results to differ materially from estimated results. Such risks and uncertainties are detailed in the Company’s filing with the Securities and Exchange Commission. Except for the statements of historical fact contained herein, certain information presented constitutes “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Such forward-looking statements, including but not limited to, those with respect to potential expansion of mineralization, potential size of mineralized zone, and size and timing of exploration and development programs, estimated project capital and other project costs and the timing of submission and receipt and availability of regulatory approvals involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievement of Almaden to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, risks related to international operations and joint ventures, the actual results of current exploration activities, conclusions of economic evaluations, uncertainty in the estimation of mineral resources, changes in project parameters as plans continue to be refined, environmental risks and hazards, increased infrastructure and/or operating costs, labour and employment matters, and government regulation and permitting requirements as well as those factors discussed in the section entitled “Risk Factors” in Almaden’s Annual Information form and Almaden’s latest Form 20-F on file with the United States Securities and Exchange Commission in Washington, D.C. Although Almaden has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Almaden disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required pursuant to applicable securities laws. Accordingly, readers should not place undue reliance on forward-looking statements.

The Toronto Stock Exchange and NYSE AMEX have not reviewed nor accepted responsibility for the adequacy or accuracy of the contents of this news release which has been prepared by management.

Contacts:
Almaden Minerals Ltd.
Morgan J. Poliquin, Ph.D., P.Eng.
President, CEO and Director
604.689.7644
604.689.7645 (FAX)
www.almadenminerals.com

China Nutrifruit Group Limited (CNGL) Announces Record Fourth Quarter and Fiscal Year 2011 Results

DAQING, Heilongjiang, China, June 22, 2011 /PRNewswire-Asia-FirstCall/ — China Nutrifruit Group Limited (NYSE Amex: CNGL) (“China Nutrifruit” or “the Company”), a leading producer of premium specialty fruit based products in China (“PRC”), today announced its financial results for the three months and fiscal year ended March 31, 2011.

Fourth Quarter Fiscal Year 2011 Highlights

• Net sales increased 21.1% year-over-year to $32.0 million
• Gross profit increased 34.2% year-over-year to $15.5 million, with gross margin of 48.3%
• Operating earnings rose 44.8% year-over-year to $12.9 million, with operating margin of 40.3%
• Net income increased 42.1% year-over-year to $9.5 million, or $0.23 per diluted share

Fiscal Year 2011 Highlights

• Net sales were $87.0 million up 19.3% from $72.9 million in fiscal 2010
• Gross profit increased 22.7% year-over-year to $40.8 million, with a gross margin of 46.9%
• Operating earnings rose 29.6% year-over-year to $33.4 million, with operating margin of 38.4%
• Net income was $24.7 million, or $0.62 per diluted share, compared to net income of $19.2 million, or $0.51 per diluted share, in fiscal 2010
• Exceeded net income guidance of $22 million to $23 million

“In fiscal 2011, we achieved record financial performance and reported double digit growth in revenue and net income, which increased 19.3% and 28.5%, respectively. During the year, we successfully introduced our new seabuckthorn and blackcurrant concentrate juice and glazed fruit products, which accounted for over 8% of fiscal 2011 sales. We also expanded our customer base to supply our products internationally through our new distributors, Cargill Shanghai and Doehler Rizhao,” commented Mr. Changjun Yu, Chairman and CEO of China Nutrifruit. “Due to delay in beginning operations of our fruit and vegetable powder facility, we reported lower than estimated revenue for fiscal year 2011. However, as a result of enhanced margins, effective cost control measures and operating efficiency, we exceeded our net income guidance for fiscal year 2011. We expect continued strong financial performance in fiscal year 2012 largely driven by anticipated growth in demand for our products combined with launch of our new fruit and vegetable powder products and concentrate paste products.”

Fourth Quarter Fiscal Year 2011 Results

Net sales for the fourth quarter of fiscal year 2011 increased 21.1% to $32.0 million, from $26.4 million in the same quarter of fiscal 2010. Strong sales growth during the quarter was primarily due to increased sales volume of glazed fruit and concentrate pulp products, and increased per unit sales price of concentrate juice products primarily resulting from the increased cost of source fruits crab apple, blueberry and raspberry. In addition, the Company’s recently introduced seabuckthorn and blackcurrant glazed fruit and concentrate juice products and they contributed 10.9% of total sales during the quarter.

In the fourth quarter of fiscal year 2011, net sales from concentrated juice products, which accounted for 47.0% of total net sales, were $15.0 million, up 3.1% from $14.6 million, or 55.2% of total net sales, in the same quarter of fiscal year 2010. Net sales from glazed fruit products reached $10.7 million, contributing 33.3% of net sales, up 65.9% as compared to $6.4 million, or 24.3% of total net sales in the same period of prior year. Sales of concentrate pulp products and nectar were $4.1 million and $2.2 million, respectively, up 37.2% and 1.1% from $3.0 million and $2.2 million, respectively, in the same period in fiscal year 2010. The Company reported no revenue from the beverage segment as it discontinued beverage operation in March 2010, following its strategic decision to focus on its high-margin premium products.

Gross profit for the fourth quarter of fiscal year 2011 increased 34.2% to $15.5 million from $11.5 million for the same period a year ago. Gross margin was 48.3% for the fourth quarter of fiscal year 2011, up from 43.6% in the year ago period. The increase in gross margin was mainly due to a significant increase in gross margin of the Company’s concentrate pulp products. Gross margin on concentrate pulp products rose to 44.7% from 27.6% a year ago. The average selling price for pear concentrate pulp increased 55.5% in the fourth quarter of fiscal 2011 compared to the same period last fiscal year. Gross margin of glazed fruit products, nectar and concentrate juice were 54.9%, 66.0% and 42.1% compared to 44.7%, 68.8% and 43.3%, respectively, in the fourth quarter of fiscal year 2010.

In the fourth quarter of fiscal year 2011, selling, general, and administrative expenses remained stable at approximately $2.6 million. Selling expenses were $0.7 million, or 2.3% of net sales, down 22.8% compared to $1.0 million, or 3.6% of net sales, in the fourth quarter of fiscal year 2010. As a percentage of net sales, decline in selling expenses was mainly due to the Company’s well established relationships with existing distributors who continue to place repeat orders with higher volume, resulting in lower sales related travel expenses. In addition, the Company incurred no selling expenses related to beverage products in the fourth quarter of fiscal year 2011.

General and administrative expenses were $1.9 million, or 5.8% of net sales, up 7.8% from $1.7 million, or 6.5% of net sales a year ago.

Operating earnings in the fourth quarter of fiscal year 2011 were $12.9 million compared to $8.9 million in the comparable period last fiscal year. Operating margin for the quarter improved to 40.3%, from 33.5 % a year ago.

Provision for income taxes for the quarter was $3.4 million compared to $2.5 million a year ago.

Net income in the fourth quarter of fiscal year 2011 was $9.5 million, or $0.23 per diluted share, up 42.1% as compared to $6.7 million, or $0.17 per diluted share, a year ago. The calculation of diluted earnings per share for the fourth quarter of fiscal 2011 is based on 40.1 million weighted average shares outstanding compared to 40.0 million in the same quarter of fiscal 2010.

Fiscal Year 2011 Results

For the fiscal year ended March 31, 2011, net sales were $87.0 million, up 19.3% from $72.9 million a year ago. Net sales from concentrate juice products, which accounted for 48.0% of total net sales in fiscal 2011, were $41.7 million, up 20.3% from $34.7 million a year ago. Among the Company’s concentrated juice products, sales of crab apple and raspberry concentrated juice increased 25.8% and 21.2%, respectively. Net sales from glazed fruit, which accounted for 25.6% of net sales, were $22.3 million, up 34.1% from $16.6 million a year ago. Sales of concentrate pulp, which accounted for 15.5% of net sales, were $13.5 million, up 43.8% from $9.4 million a year ago. Sales of nectar, which accounted for 8.3% of net sales, were $7.2 million, up 3.9% from $7.0 million a year ago. The Company did not record sales from beverages since it ceased the production of beverages in March 2010 to strategically focus on its core high-margin products.

Gross profit increased 22.7% to $40.8 million from $33.3 million a year ago. Gross margin was 46.9% in fiscal year 2011 compared to 45.6% a year ago. Income from operations was $33.4 million, up 29.6% from $25.7 million last year. Net income for fiscal 2011 was $24.7 million, or $0.62 per diluted share, compared to $19.2 million, or $0.51 per diluted share in fiscal 2010. The calculation of diluted earnings per share for fiscal 2011 is based on 40.1 million weighted average shares outstanding compared to 38.1 million in fiscal 2010.

Financial Condition

As of March 31, 2011, China Nutrifruit had $43.5 million in cash and equivalents, $7.7 million in current liabilities with no long-term debt and working capital of $55.0 million. Shareholders’ equity was $93.3 million as of March 31, 2011, up from $65.8 million as of March 31, 2010.

The Company generated $25.8 million net cash from operating activities, up from $21.7 million generated in fiscal year 2010. The Company used $16.4 million in prepayment for purchase of land use right, property and equipment for the construction of the Company’s new fruit and vegetable powder facility in Daqing, which is scheduled to begin operations in July2011.

Business Outlook

In fiscal 2012, China Nutrifruit plans to further expand production capacity, diversify its product portfolio and increase market penetration. The Company will launch its new fruit and vegetable powder products, concentrate paste products, cherry tomato glazed fruits and golden berry dried fruits in calendar year 2011.

The Company is currently constructing a new concentrate paste production facility in Zhaoyuan, Heilongjiang Province and plans to begin trial production in July 2011. This new multi-purpose concentrate paste production facility will have an annual production capacity of 9,600 tons and will catering to the raw material requirements of the Company’s new fruit and vegetable powder production facility and will also be sold to existing distributors.

China Nutrifruit is currently making technological upgrades to its glazed fruit production line in Daqing and concentrate juice production line in Mudanjiang. The Company expects to complete the upgrade process by July 2011 in advance of its production season. As part of the technological upgrade process, the Company is installing additional processing equipment at its glazed fruit production line in Daqing, which will enable production of its new golden berry dried fruit products. In addition, following technological and maintenance upgrades, the Company’s concentrate juice production capacity in Mudanjiang will expand to 9,000 tons annually, up 50% from its current annual capacity of 6,000 tons per year.

For fiscal year 2012, the Company expects to generate revenue of approximately $110 million to $113 million and net income of approximately $29 million to $30 million,

“Looking into fiscal 2012, we continue to see strong demand for our high quality products backed by strong customer loyalty and an increasingly health-conscious environment,” said Mr. Yu. “We are on track to commence production of our fruit and vegetable powder products in July 2011. In addition, we are excited about our strong product pipeline, including cherry tomato glazed fruit, dried fruit products and concentrate paste products, which will be supported by our capacity expansion plans. We will be leveraging our existing nationwide sales and distribution network throughout 18 provinces in China to market our new products and hold a positive outlook. With our proven business model, strong execution capability, new product initiatives, and capacity expansion, we believe we are well-positioned to achieve another year of record financial performance in fiscal 2012.”

Conference Call Information

Management will conduct a conference call at 9:00 a.m. Eastern Time on Wednesday, June 22, 2011, to discuss financial results for the fourth quarter and fiscal year 2011, ended March 31, 2011.

To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: (866) 759-2078. International callers should dial +1-706-643-0585. The conference ID number for the call is 75696956.

If you are unable to participate in the call at this time, a replay will be available on Wednesday, June 22, 2011 at 12:00 noon Eastern Time, through Wednesday, July 6, 2011. To access the replay, dial 800-642-1687. International callers should dial +1-706-645-9291. The conference ID number for the replay is 75696956.

About China Nutrifruit Group Limited

Through its subsidiaries Daqing Longheda Food Company Limited and Daqing Senyang Fruit and Vegetable Food Technology Company Limited, China Nutrifruit, is engaged in developing, processing, marketing and distributing a variety of food products processed primarily from premium specialty fruits grown in Northeast China, including golden berry, crab apple, blueberry, seabuckthorn, blackcurrant and raspberry. Its processing facility possesses ISO9001 and HACCP series qualifications. Currently, the Company has established an extensive nationwide sales and distribution network throughout 18 provinces in China. For more information, please visit http://www.chinanutrifruit.com .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act””). Such statements include, among others, those concerning our new products, our new facility and capacity expansion, and its expected impact on the Company’s business and financial performance, our expectations regarding the market for our existing products and new products, our expected financial performance and strategic and operational plans, as well as all assumptions, expectations, predictions, intentions or beliefs about future events. You are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause actual results of the Company to differ materially from those anticipated, expressed or implied in the forward-looking statements. The words “believe,” “expect,” “anticipate,” “project,” “targets,” “optimistic,” “intend,” “aim,” “will” or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those anticipated include risks related to new and existing products; any projections of sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements regarding future economic conditions or performance; uncertainties related to conducting business in China; any statements of belief or intention; any of the factors mentioned in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended March 31, 2011, and other risks and uncertainties mentioned in our other reports filed with the Securities and Exchange Commission. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.

— Financial Tables Follow —

Achillion Pharmaceuticals (ACHN) Announces Pricing of Public Offering of Common Stock

NEW HAVEN, Conn., June 22, 2011 (GLOBE NEWSWIRE) — Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today the pricing of an underwritten public offering of 9,600,000 shares of its common stock at a price to the public of $5.90 per share. The net proceeds to Achillion from the sale of the shares, after deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $52.9 million. The offering is expected to close on June 27, 2011, subject to customary closing conditions. BofA Merrill Lynch and Leerink Swann LLC are acting as joint book-running managers for the offering.

Achillion has granted the underwriters a 30-day option to purchase up to an additional 1,440,000 shares of its common stock to cover overallotments, if any. The expected net proceeds to Achillion referenced above do not include any net proceeds that Achillion would receive if the underwriters exercise such overallotment option.

The offering is being made by Achillion pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC). A prospectus supplement related to the offering will be filed with the SEC and will be available on the SEC’s website at http://www.sec.gov. Copies of the prospectus supplement, when available, and the accompanying prospectus relating to this offering may be obtained from BofA Merrill Lynch, 4 World Financial Center, New York, NY 10080, Attn: Prospectus Department or email dg.prospectus_requests@baml.com or from Leerink Swann LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, telephone number (800) 808-7525, Ext. 4814.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor will there be any sale of, these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or other jurisdiction.

About Achillion Pharmaceuticals, Inc.

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease.

Forward-Looking Statements

This press release includes “forward-looking statements” made under the provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements, other than statements of historical fact, regarding, without limitation, the completion, timing and size of Achillion’s proposed public offering. In some cases, words such as “will,” “expect” or other comparable words identify forward-looking statements. Actual results, performance or experience may differ materially from those expressed or implied by any forward-looking statement as a result of various important factors, including without limitation risks and uncertainties relating to Achillion’s business and financial condition, general market conditions and the satisfaction of customary closing conditions associated with the proposed public offering. Risks and uncertainties that Achillion faces are described in greater detail under the heading “Risk Factors” in its Form 8-K filed on June 20, 2011 and in other filings that it makes with the SEC. As a result of the risks and uncertainties, the results or events indicated by any forward-looking statement may not occur. Achillion cautions you not to place undue reliance on any forward-looking statement.

In addition, any forward-looking statement in this press release represents Achillion’s views only as of the date of this press release and should not be relied upon as representing its views as of any subsequent date. Achillion disclaims any obligation to update any forward-looking statement, except as required by applicable law.

CONTACT: Corporate Contact:
         Glenn Schulman
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 752-5510
         gschulman@achillion.com

         Investor Contact:
         Mary Kay Fenton
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 624-7000
         mfenton@achillion.com

         Media Contact:
         Christin Culotta Miller
         Ogilvy PR
         Tel. (646) 229-5178
         christin.miller@ogilvypr.com

AeroVironment, Inc. (AVAV) Announces Fiscal 2011 Fourth Quarter and Fiscal Year End Results

Jun. 21, 2011 (Business Wire) — AeroVironment, Inc. (NASDAQ: AVAV) today reported financial results for its fourth quarter and fiscal year ending April 30, 2011.

“With record fourth quarter revenue of $106.1 million, fiscal 2011 revenue grew 17% to $292.5 million, exceeding our guidance, and diluted earnings per share increased 24% to $1.17,” said Tim Conver, AeroVironment chairman and chief executive officer. “Electric vehicle charging solutions and digital Puma unmanned aircraft systems successfully transitioned from development to production programs with attractive long-term growth prospects, while other innovative developments progressed toward customer adoption. The effective performance of our team, the successful transition of great ideas to meaningful market adoption with first mover advantage and the strong demand for our solutions continue to position us well for long-term growth.”

FISCAL 2011 FOURTH QUARTER RESULTS

Revenue for the fourth quarter of fiscal 2011 was $106.1 million, up 7% over fourth quarter fiscal 2010 revenue of $99.4 million. The increase in revenue resulted from increased sales in our Efficient Energy Systems (EES) segment of $7.8 million offset by decreased sales in our Unmanned Aircraft Systems (UAS) segment of $1.1 million.

Income from operations for the fourth quarter of fiscal 2011 was $25.2 million, up 7% from fourth quarter fiscal 2010 income from operations of $23.5 million. The increase in income from operations resulted from higher gross margin of $6.2 million offset by higher selling, general and administrative (SG&A) expense of $1.2 million and higher research and development (R&D) expense of $3.3 million.

Net income for the fourth quarter of fiscal 2011 was $17.6 million, up 13% from fourth quarter fiscal 2010 net income of $15.6 million.

Earnings per diluted share for the fourth quarter of fiscal 2011 were $0.79, up 11% from fourth quarter fiscal 2010 earnings per diluted share of $0.71.

FISCAL 2011 FULL YEAR RESULTS

Revenue for fiscal year 2011 was $292.5 million, up 17% over fiscal year 2010 revenue of $249.5 million. The increase in revenue resulted from increased sales in our UAS segment of $25.6 million and EES segment of $17.4 million.

Income from operations for fiscal year 2011 was $34.0 million, up 14% from fiscal year 2010 income from operations of $29.9 million. The increase in income from operations resulted from higher gross margin of $20.3 million offset by higher SG&A expense of $5.0 million and higher R&D expense of $11.3 million.

Net income for fiscal year 2011 was $25.9 million, up 25% from fiscal year 2010 net income of $20.7 million.

Earnings per diluted share for fiscal year 2011 were $1.17, up 24% from fiscal 2010 earnings per diluted share of $0.94.

BACKLOG

As of April 30, 2011, funded backlog (unfilled firm orders for which funding is currently appropriated to us under a customer contract) was $82.9 million compared to $72.3 million as of April 30, 2010.

FISCAL 2012 — OUTLOOK FOR THE FULL YEAR

For fiscal year 2012, the Company expects to generate revenue of $321 million to $336 million, and earnings per share of $1.28 to $1.35 on a fully diluted basis.

The foregoing estimates are forward looking and reflect management’s view of current and future market conditions, including certain assumptions with respect to our ability to obtain and retain government contracts, changes in the demand for our products and services, activities of competitors and changes in the regulatory environment, and general economic and business conditions in the United States and elsewhere in the world. Investors are reminded that actual results may differ materially from these estimates.

CONFERENCE CALL

In conjunction with this release, AeroVironment, Inc. will host a conference call today, Tuesday, June 21, 2011, at 1:30 pm Pacific Time that will be broadcast live over the Internet. Timothy E. Conver, chairman and chief executive officer, Jikun Kim, chief financial officer, and Steven A. Gitlin, vice president of investor relations, will host the call.

4:30 PM ET

3:30 PM CT

2:30 PM MT

1:30 PM PT

Investors may dial into the call at (877) 561-2749 (U.S.) or (678) 809-1029 (international) five to ten minutes prior to the start time to allow for registration.

Investors with Internet access may listen to the live audio webcast via the “Investors” section of the AeroVironment, Inc. website, http://investor.avinc.com. Please allow 15 minutes prior to the call to download and install any necessary audio software. An audio replay of the event will be archived on the Investor Relations page of the Company’s website, at http://investor.avinc.com.

An audio replay of the call will be available on Tuesday, June 21, 2011, at approximately 4:30 p.m. Pacific Time through Tuesday, June 28, at 9:00 p.m. Pacific Time. Dial 800-642-1687 and enter the passcode 71377219. International callers should dial 706-645-9291 and enter the same passcode number to access the digital replay.

ABOUT AEROVIRONMENT, INC.

AeroVironment is a technology solutions provider that designs, develops, produces and supports an advanced portfolio of Unmanned Aircraft Systems (UAS) and electric transportation solutions. Agencies of the U.S. Department of Defense and allied military services use the company’s battery-powered, hand-launched unmanned aircraft systems extensively to provide situational awareness to tactical operating units through real-time, airborne reconnaissance, surveillance and communication. AeroVironment’s electric transportation solutions include a comprehensive suite of electric vehicle (EV) charging systems and installation services for consumers, automakers, utilities and government agencies, power cycling and test systems for EV developers and industrial electric vehicle charging systems for commercial fleets. More information about AeroVironment is available at www.avinc.com.

FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words such as “believe,” “anticipate,” “expect,” “estimate,” “intend,” “project,” “plan,” or words or phrases with similar meaning. Forward-looking statements are based on current expectations, forecasts and assumptions that involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and technological factors outside of our control, that may cause our business, strategy or actual results to differ materially from the forward-looking statements. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, reliance on sales to the U.S. government; changes in the supply and/or demand and/or prices for our products; the activities of competitors; failure of the markets in which we operate to grow; failure to expand into new markets; changes in significant operating expenses, including components and raw materials; failure to develop new products; changes in the regulatory environment; and general economic and business conditions in the United States and elsewhere in the world. For a further list and description of such risks and uncertainties, see the reports we file with the Securities and Exchange Commission. We do not intend, and undertake no obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Additional AV News: http://avinc.com/resources/news/

AV Media Gallery: http://avinc.com/media_gallery/

Follow us: www.twitter.com/aerovironment

AeroVironment, Inc.

Steven Gitlin, +1 626-357-9983

ir@avinc.com

Heather Rowe, +1 626-357-9983

ir@avinc.com

Gold Resource Corporation (GORO) Acquires Sixth Property

COLORADO SPRINGS, CO — (Marketwire) — 06/20/11 — Gold Resource Corporation (GORO) (NYSE Amex: GORO) is pleased to announce having significantly increased its land position adding a sixth potential high-grade property to the Company’s Oaxaca Mining Unit. Gold Resource Corporation is a low-cost gold producer with operations in southern Mexico.

The Company staked several new claims including El Chamizo consisting of 26,386 hectares (101 square miles) connecting the Company’s Alta Gracia property to its El Rey property effectively consolidating approximately 48 kilometers (29 miles) along strike of the important north 70 west regional structural corridor. With this new acquisition, Gold Resource Corporation has 100% interest in 60,998 hectares (235 square miles) located in Oaxaca, Mexico. The combined claims represent the Company’s sixth property added to its Oaxaca Mining Unit (see map), now consisting of El Aguila, El Rey, Alta Gracia, Las Margaritas, El Chamizo and Solaga. In addition, the Company staked a 2000 hectare (7 square miles) claim located on the southeast end of the corridor which adds to and increases the size of the Aguila Project.

Gold Resource Corporation’s President, Mr. Jason Reid, stated, “After much work and patience, we have methodically consolidated a dominant land position now connecting five properties on what we believe will become one of the most important mineralized structural corridors in southern Mexico.”

“On the southeast end of the corridor is our Aguila Project, home to our largest high-grade polymetallic deposit discovered to date, La Arista. On the corridor’s northwest end is the Company’s El Rey property, a high-grade gold vein system established by our limited drilling in 2008. In the middle of the corridor is the Alta Gracia property, previously mined on a small scale in the 1970s, where a recent Company drill program commenced testing many high-grade targets. The new property Chamizo, located between Alta Gracia and El Rey, is a major increase to our land holdings along what we believe is a highly mineralized corridor,” stated Mr. Reid.

Mr. Reid continued, “This acquisition is in line with our long term objective of having multiple high-grade properties feeding ore to the Aguila mill. Our approach should keep capital expenditures on developing additional properties to a minimum, deliver a pipeline of projects for future growth and provide for longevity of operations.”

About GRC:
Gold Resource Corporation is a mining company focused on production and pursuing development of gold and silver projects that feature low operating costs and produce high returns on capital. The Company has 100% interest in six potential high-grade gold and silver properties in Mexico’s southern state of Oaxaca. The Company has 52,998,303 shares outstanding, no warrants and no debt. For more information, please visit GRC’s website, located at www.Goldresourcecorp.com and read the Company’s 10-K for an understanding of the risk factors involved.

This press release contains forward-looking statements that involve risks and uncertainties. The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. When used in this press release, the words “plan,” “target,” “anticipate,” “believe,” “estimate,” “intend” and “expect” and similar expressions are intended to identify such forward-looking statements. Such forward-looking statements include, without limitation, the statements regarding Gold Resource Corporation’s strategy, future plans for production, future expenses and costs, future liquidity and capital resources, and estimates of mineralized material. All forward-looking statements in this press release are based upon information available to Gold Resource Corporation on the date of this press release, and the company assumes no obligation to update any such forward-looking statements. Forward looking statements involve a number of risks and uncertainties, and there can be no assurance that such statements will prove to be accurate. The Company’s actual results could differ materially from those discussed in this press release. In particular, there can be no assurance that production will continue at any specific rate. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the company’s 10-K filed with the Securities and Exchange Commission.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1649196

Contact:
Greg Patterson
Corporate Development
303-320-7708

Himax (HIMX) Reiterates Second Quarter Guidance and Announces Share Buyback

TAINAN, Taiwan, June 20, 2011 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (“Himax” or “Company”) (Nasdaq:HIMX) today reiterated its second quarter guidance and announced a $25 million share buyback program. Himax Board of Directors today approved a share buyback program that authorizes the Company to repurchase up to $25 million of the Company’s American Depository Shares (“ADSs”) in the open market or through privately negotiated transactions. The program does not obligate Himax to acquire any particular amount of ADSs and may be modified or suspended at any time at the Company’s sole discretion.

Jordan Wu, President and Chief Executive Officer of Himax, commented, “As of today, we expect our second quarter revenues to go up 10% to 15%, in line with the guidance we previously provided in our last earnings call on May 9, 2011. While we reiterate the second quarter guidance, the actual results remain subject to market changes and other future events that may occur before the quarter end.”

Mr. Wu continued, “We remain firmly confident in our long-term business outlook. Our ADSs are undervalued, currently trading below book value of approximately US$2.3 per ADS as of May 31, 2011. We believe a share buyback program demonstrates the strong commitment from the Board and the management team to enhance shareholder value.”

About Himax Technologies, Inc.

Himax Technologies, Inc. designs, develops, and markets semiconductors that are critical components of flat panel displays. The Company’s principal products are display drivers for large-sized TFT-LCD panels, which are used in desktop monitors, notebook computers and televisions, and display drivers for small- and medium-sized TFT-LCD panels, which are used in mobile handsets and consumer electronics products such as tablet PCs, netbook computers, digital cameras, mobile gaming devices, portable DVD players, digital photo frame and car navigation displays. In addition, the Company is expanding its product offerings to include timing controllers, touch controller ICs, LCD TV and monitor chipset solutions, LCOS projector solutions, power management ICs, CMOS image sensors, infinitely color technology and 2D to 3D conversion solutions. Based in Tainan, Taiwan, the Company has regional offices in Hsinchu and Taipei, Taiwan; Ninbo, Foshan, Fuqing, Beijing, Shanghai, Suzhou and Shenzhen, China; Yokohama and Matsusaka, Japan; Cheonan-si, Chungcheongnam-do, South Korea; and Irvine, California, USA.

Forward-Looking Statements:

Factors that could cause actual events or results to differ materially include, but not limited to, general business and economic conditions and the state of the semiconductor industry; market acceptance and competitiveness of the driver and non-driver products developed by the Company; demand for end-use applications products; reliance on a small group of principal customers; the uncertainty of continued success in technological innovations; our ability to develop and protect our intellectual property; pricing pressures including declines in average selling prices; changes in customer order patterns; changes in estimated full-year effective tax rate; shortages in supply of key components; changes in environmental laws and regulations; exchange rate fluctuations; regulatory approvals for further investments in our subsidiaries; our ability to collect accounts receivable and manage inventory; the uncertainty of success in our Taiwan listing plan which is still under review by Taiwan regulatory authorities and subject to change due to, among other things, changes in either Taiwan or US authorities’ policies and Taiwan regulatory authorities’ acceptance of the Company’s Taiwan listing application and other risks described from time to time in the Company’s SEC filings, including those risks identified in the section entitled “Risk Factors” in its Form 20-F for the year ended December 31, 2010 filed with the SEC on May 20, 2011, as may be amended.

CONTACT:  Jessie Wang / Jessica Huang
          Investor Relations
          Himax Technologies, Inc.
          +886-2-2370-3999 Ext. 22618 / 22513
          jessie_wang@himax.com.tw
          jessica_huang@himax.com.tw

          In the U.S.
          Joseph Villalta
          The Ruth Group
          +1-646-536-7003
          jvillalta@theruthgroup.com

Pfizer and Acura (ACUR) Announce FDA Approval of Oxectatm (Oxycodone HCL, USP) CII

Jun. 20, 2011 (Business Wire) — Pfizer Inc. (NYSE: PFE) and Acura Pharmaceuticals Inc. (NASDAQ: ACUR) announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTA^TM (oxycodone HCl, USP) Tablets CII. OXECTA is indicated for the management of acute and chronic moderate to severe pain where the use of an opioid analgesic is appropriate.

OXECTA is the first immediate-release oxycodone HCl medicine that applies technology designed to discourage common methods of tampering associated with opioid abuse and misuse. This AVERSION^® Technology is a unique composition of commonly used pharmaceutical ingredients. Pfizer is licensing the technology in OXECTA from Acura.

Opioid medications are an important treatment option for patients with moderate to severe pain who are not adequately managed by other pain treatments. However, abuse and misuse of opioids is a serious public health issue that is the focus of a number of recent United States government initiatives.

“We recognize our responsibility to physicians and patients and remain committed to appropriate access to pain treatment and developing medicines to potentially address this important public health and safety issue,” said Olivier Brandicourt, Pfizer president and general manager, Primary Care. “OXECTA will further expand Pfizer’s presence in pain management and complements our growing, robust portfolio of treatments and medicines in development for pain relief, one of our strategic, high-priority disease areas. We are pleased to bring OXECTA to patients and physicians with our partner Acura.”

“We are excited to be partnered with Pfizer to bring OXECTA to patients who need opioids to manage their pain,” said Robert Jones, interim president and chief executive officer of Acura Pharmaceuticals, Inc. ”Acura is focused on developing technologies that are intended to potentially deter abuse and misuse.”

Important Safety Information

OXECTA is contraindicated in patients with respiratory depression in unmonitored settings and in the absence of resuscitative equipment, in any patient who has or is suspected of having paralytic ileus, in patients with acute or severe bronchial asthma or hypercarbia, and in patients with known hypersensitivity to oxycodone, oxycodone salts, or any components of the product.

Respiratory depression is the primary risk of OXECTA. This is more common in elderly or debilitated patients, in those suffering from conditions such as COPD, severe asthma, or upper airway obstruction, or following large initial doses of opioids given to non-tolerant patients.

OXECTA contains oxycodone HCl, an opioid agonist and a Schedule II controlled substance. Such drugs are sought by drug abusers and people with addictions. OXECTA can be abused in a manner similar to other opioids and narcotics. This should be considered when prescribing or dispensing oxycodone HCl in situations where the physician or pharmacist is concerned about an increased risk of misuse or abuse. OXECTA may be abused by crushing, chewing, snorting or injecting the product. These practices pose a significant risk to the abuser that could result in overdose and death. OXECTA should not be given to anyone other than the individual for whom it was prescribed. Keep OXECTA in a locked cabinet, drawer or medicine safe so that it will not be stolen.

There is no evidence that OXECTA has a reduced abuse liability compared to immediate-release oxycodone.

Take each OXECTA tablet with enough water to ensure complete swallowing immediately after placing in the mouth, and OXECTA must be swallowed whole. As OXECTA is not amenable to crushing and dissolution, do not use OXECTA in nasogastric, gastric or other feeding tubes as it may cause obstruction of feeding tubes.

Patients who have not been receiving opioid analgesics should start on OXECTA in a dosing range of 5 to 15 mg every 4 to 6 hours as needed for pain. The dose should be titrated based upon the individual patient’s response to their first dose of OXECTA. Patients with chronic pain may need to be dosed at the lowest dosage level that will achieve acceptable pain relief and tolerable adverse reactions, on an around-the-clock basis rather than on an as needed basis. When a patient no longer needs treatment with OXECTA after long-term use, it is important to gradually taper OXECTA over time to prevent withdrawal symptoms.

Patients taking OXECTA in combination with other medicines like sedatives, anesthetics or narcotics may have serious problems such as respiratory depression, low blood pressure, profound sedation, or coma. Do not drink alcoholic beverages or take any medicines containing alcohol while taking OXECTA.

Use OXECTA with caution in patients with head injuries or other conditions that increase pressure in the brain, shock with low blood volume, severe undiagnosed abdominal conditions, history of seizures, severe kidney or liver disease, gall bladder disease, Addison’s disease, hypothyroidism, enlarged prostate or other illnesses that make urination difficult and elderly or debilitated patients. Do not use OXECTA in patients with intestinal obstruction especially paralytic ileus.

Patients taking OXECTA should use caution when driving a car, operating heavy machinery or doing similar, potentially dangerous tasks as OXECTA may impair abilities needed to drive or perform potentially dangerous activities.

The most common adverse reactions are nausea, constipation, vomiting, headache, itchiness, trouble sleeping, dizziness, loss of strength/energy, and sleepiness.

Keep OXECTA out of the reach of children. If a child accidently takes OXECTA, seek emergency medical help immediately.

For additional information on the prescribing information for OXECTA, please call 1 (800) 776-3637.

Pfizer Inc.: Working Together for a Healthier World™

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

To learn more about our commitments, please visit us at www.pfizer.com.

About Acura Pharmaceuticals

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and commercialization of product candidates intended to potentially deter abuse and misuse utilizing its proprietary AVERSION^® and IMPEDE^® technologies.

Acura will receive a $20 million milestone payment from Pfizer based on the approval of OXECTA.

Acura Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”). Acura Pharmaceuticals, Inc. disclaims any intent or obligation to update these forward-looking statements, and claim the protection of the Safe Harbor for forward-looking statements contained in the Act. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Important factors that may cause actual results to differ materially from the forward-looking statements are discussed in the “Risk Factors” section and other sections of the Companies’ -6-

Annual Reports on Form 10-K for the fiscal year ended December 31, 2010, and their Quarterly Reports on Form 10-Q for the quarter ended March 31, 2011, each of which is on file with the U.S. Securities and Exchange Commission.

Pfizer Contacts:

MacKay Jimeson, 212-733-2324 (media)

Jennifer Davis, 212-733-0717 (investors)

or

Acura Contact:

Peter A. Clemens, 847-705-7709

Harbin Electric (HRBN) Enters Into Merger Agreement to Be Acquired for $24.00 per Share in Cash

SmartHeat Inc. (HEAT)

SmartHeat Inc. designs, manufactures, sells, and services plate heat exchangers (PHE) and related systems used in the industrial, residential, and commercial markets in the People’s Republic of China. The company’s products and systems are used in various applications, including energy conversion for heating, ventilation, and air conditioning; and industrial use in petroleum refining, petrochemicals, metallurgy, food and beverage, and chemical processing.

Offering a full line of products customizable to customer specification, the company sells PHEs under the Taiyu and Sondex names, and PHE units under the Taiyu name. SmartHeat markets its products through its sales force, as well as through a network of 26 national distributors. Notable clients of SmartHeat include Motorola, Dalkia, Veolia, BeijingInternationalAirport, Sinopec, and ACIC Air and many others.

In just 5 years of operations, the company’s team of engineers and researchers has developed 6 key national patents used across various product lines. SmartHeat’s PHE Units help industrial and commercial users save energy, decrease costs, and control temperatures, whether for industrial processing or for commercial and home use, while helping China meet its 21st century energy needs.

Currently trading at a P/E of only 3.5 and P/S of 0.32, the company is considered severely undervalued when compared to other publicly traded companies in the same industry. Also notable, SmartHeat’s market price is far below the company’s book value per share of $3.92 and the average analyst price target is more than triple the current stock price.

Key statistics (9/6/11):

Market cap: $33.19 Million
P/E Ratio: 3.5 versus industry average of 14.7
P/S Ratio: 0.32 versus industry average of 1.34
Price/Cash Flow Ratio: 4.20 versus industry average of 10.00

Debt/Equity Ratio: 0.11 versus industry average of 0.53
Current Ratio: 4.9 versus industry average of 2.0
Quick Ratio: 3.5 versus industry average of 1.3
Book Value/Share: $3.92 versus current market price of $0.86

Return on Equity: 5.7% versus industry average of 20.2%
Return on Assets: 4.8% versus industry average of 8.7%
Return on Capital: 5.6% versus industry average of 11.9%
Inventory Turnover: 2.3 versus industry average of 6.1

China North East Petroleum (NEP) Set to Join Russell Microcap Index

HARBIN, China and NEW YORK, June 15, 2011 /PRNewswire-Asia-FirstCall/ — China North East Petroleum Holdings Limited (the “Company”) (NYSE Amex: NEP), a leading independent oil producing and oilfield services company in Northern China, will join the Russell Microcap® Index when Russell Investments reconstitutes its family of U.S. indexes on June 24, according to a preliminary list of additions posted June 10 on www.russell.com/indexes.

Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

Mr. Jingfu Li, CEO of China North East Petroleum commented, “Our inclusion in the Russell Microcap index is a milestone event for NEP and can increase our visibility within the investment community. We are pleased to be included among the well respected companies in this index and look forward to the continued execution of our strategic operational initiatives.”

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. An industry-leading $3.9 trillion in institutional assets currently are benchmarked to them.

Annual reconstitution of Russell Indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000® Index and Russell Microcap. These investment tools originated from Russell’s multi-manager investment business in the early 1980s when the company saw the need for a more objective, market-driven set of benchmarks in order to evaluate outside investment managers.

More information on the Russell Microcap and other Russell Indexes, including daily returns, is available at http://www.russell.com/Indexes/data/default.asp.

About Russell

Russell Investments provides strategic advice, world-class implementation, state-of-the-art performance benchmarks and a range of institutional-quality investment products. Russell has more than $161 billion in assets under management as of March 31 2011, and serves individual, institutional and advisor clients in more than 35 countries. Founded in 1936, Russell is a subsidiary of The Northwestern Mutual Life Insurance Company.

ABOUT CHINA NORTH EAST PETROLEUM

China North East Petroleum Holdings Limited is an independent oil company that engages in the production of crude oil in Northern China. The Company is a pioneer in China’s private oil exploration and production industry, and the first Chinese non-state-owned oil company trading on the NYSE Amex.

The Company has a guaranteed arrangement with the PetroChina to sell its produced crude oil for use in the China marketplace. The Company currently operates four oilfields in Northern China. The Company also recently added an oil service subsidiary through its acquisition of Song Yuan Tiancheng Drilling Engineering Co. Ltd. (“Tiancheng”). For more information about the Company, please visit http://www.cnepetroleum.com.

Statements in this press release, including but not limited to those relating to the Company’s or management’s intentions, beliefs, expectations, hopes, projections, assessment of risks, estimations, plans or predictions for the future, including the impact of the restatement, timing of filings with the SEC and other statements that are not historical facts are forward-looking statements that are based on current expectations. Statements regarding our ability to realize future production volumes, realize success in our drilling and development activity and forecasts of legal claims, prices, future revenues and income and cash flows and other statements that are not historical facts contain predictions, estimates and other forward-looking statements. Although the Company believes that its expectations are based on reasonable assumptions, it can give no assurance that these expectations will prove correct. Important factors that could cause actual results to differ materially from those in the forward-looking statements include delays and uncertainties that may be encountered in connection with seismic testing and test drilling in the Durimu oilfield, the anticipated benefits from the acquisition cannot be fully realized, the possibility that costs or difficulties related to the development of the Durimu oilfield will be greater than expected, and other risks described in the Company’s annual report on Form 10-K for the year ended December 31, 2010 and its other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Investors should not place undue reliance on forward-looking statements. Each forward-looking statement speaks only as of the date of the particular statement and the Company undertakes no duty to update any forward-looking statement.

Ener1 (HEV) and Federal Grid Company to Demonstrate Lithium-Ion Distributed Energy Storage System

NEW YORK, June 15, 2011 /PRNewswire/ — Ener1, Inc. (NASDAQ: HEV) and the Russian Federal Grid Company (FGC) (MICEX: FEES) today announced they will display a fully operational, lithium-ion, distributed energy storage system as part of the 15th annual St. Petersburg International Economic Forum which will be held June 16-18 in Russia. The Forum will be attended by more than 2,500 people. Leading the roster of government leaders and corporate CEOs from around the world are opening speeches by the President of the Russian Federation, Dmitry Medvedev, and the President of the People’s Republic of China, Hu Jintao.

(Logo: http://photos.prnewswire.com/prnh/20080312/CLW018LOGO )

Ener1 and FGC will be displaying a 70 kWh distributed energy storage system. While the unit is a smaller version of the large-scale solutions the companies are co-developing as part of an agreement signed last November, it will provide attendees an understanding of how the two companies can strategically manage power storage for the country’s electric grid. The large-scale distributed energy storage systems being developed — which will be used for emergency back-up power at FGC substations in St. Petersburg and the Black Sea port city of Sochi, site of the 2014 Winter Olympic Games — are scheduled to be installed in Russia in the next few months. The first unit will be shipped in the next few weeks.

“Ener1 is committed to working with FGC as part of its effort to support Russia’s $15-billion investment to modernize the country’s electric grid infrastructure through 2012,” said Ener1 Chairman and CEO Charles Gassenheimer. “Together, we’re developing energy storage solutions that we hope will leap-frog the current infrastructure and leverage the benefits of a smart grid technology, which could ultimately save FGC and its customers millions of dollars.”

“We’ve been working with FGC’s Mobile GTES subsidiary to develop and manufacture two distributed energy storage systems,” said Bruce Curtis, president of grid energy storage solutions for Ener1. “When the units are installed this fall, we believe they will provide viable solutions to help strengthen Russia’s electric grid in two demanding regions, provide emergency back-up power for substation auxiliaries, and offer future integration for intermittent renewable energy sources.”

Due to the growth in renewable energy sources like wind and solar and the need to modernize electric utility grids, the energy storage market is expected to grow to approximately $2.5 billion globally by 2015*. With expertise developed over the last few years, Ener1 hopes to work with utility partners and contractors in countries like the U.S., Japan, Germany, Russia, India and Brazil to deliver the right energy storage system — including distributed, community or bulk energy storage solutions — to address their power needs.

“We’ve been collaborating with Ener1 to develop lithium-ion-based energy storage solutions for Russia’s Unified National Power Grid to help improve the reliability of power delivery to our customers,” stated Oleg Bragin, general director, Mobile GTES. “At the Forum, we plan to demonstrate just how far we’ve come in such a short time in developing the distributed energy storage systems we’re installing this fall in St. Petersburg and Sochi.”

As part of the St. Petersburg event, the FGC is also sponsoring an invitation-only roundtable entitled “Smart Grids: Projects of the Future,” which is designed to educate and encourage debate around issues critical to wide-spread smart grid deployment around the world. Ener1 Chairman and CEO Charles Gassenheimer will be one of the industry experts providing perspectives on the future direction of lithium-ion-based bulk energy storage solutions for smarter electric grids. The roster of six speakers includes from the U.S.:

• George Arnold, national coordinator for smart grid interoperability, National Institute of Standards and Technology (NIST)
• Terry Boston, president and chief executive officer, PJM Interconnection

About Ener1, Inc.

Ener1, Inc. is a publicly traded (NASDAQ: HEV) energy storage technology company that develops compact, lithium-ion-powered battery solutions for the transportation, utility grid and industrial electronics markets. Headquartered in New York City, the company has more than 700 employees with manufacturing locations in the United States and Korea. Ener1 also develops commercial fuel cell products and nanotechnology-based materials.

About Federal Grid Company

Open Joint-Stock Company Federal Grid Company of the Unified Energy System provides unified national electric grid management to the power industry in the Russian Federation. It offers energy transmission services; technical connection services, including services for electric power consumption (delivery), as well as providing actual connection of consumers’ electric devices to the electric grid facilities to legal entities and individuals; and technical maintenance and repair of facilities in the unified national electric grid system. The company also invests in and develops the unified energy system.

About Mobile GTES

Joint-stock company Mobile GTES is a wholly owned subsidiary of Federal Grid Company. It was established in 2006 to deploy and operate mobile gas turbine power stations with a view to maintaining the reliability of the Moscow region’s power grid at peak hours in the most effective, safe and ecologically pure manner. Mobile GTES was also created to be able to promptly relocate such power plants to remote regions of Russia with inadequate electricity supplies. The company possesses vast experience in commissioning and operating mobile gas turbine power plants and selling capacity and power on the wholesale market.

Safe Harbor Statement

Certain statements made in this press release constitute forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

* Source: Greentech Media Inc., August 2009.

Media Contacts:
Ener1, Inc.
Brian Sinderson
+1 212.920.3500 X117
brian.sinderson@ener1.com

Local.com (LOCM) Launches First Integrated Advertising Product from Krillion and Rovion Acquisitions

Jun. 15, 2011 (Business Wire) — Local.com Corporation (NASDAQ: LOCM), a leading online local media company, today announced the launch of its first integrated solution resulting from the recent Krillion and Rovion acquisitions.

The dynamic, geo-targeted rich media ad units from Rovion provide real-time data from Krillion on products that are geographically local to each user, including information on current discounts, pricing, product details, store locations and in-stock availability. Local.com plans to distribute these dynamic ads across its network of more than 1,400 regional media publishers’ websites, as well as third-party partner networks, which will create additional reach. To see an example of the ad unit go to: http://www.local.com/business/details/lake-forest-ca/sears-80315212/.

The company generates revenue from the retailers when consumers click on the ad units. National brands with local points of presence increasingly use display advertising, and rich media in particular, to more effectively target local consumers. According to industry research, rich media ads can outperform standard and animated counterparts by 300 percent or more. Recent research from Yahoo! indicates that hyper-local targeting of retail display campaigns generates more than five times return-on-ad-spend measured by sales lift at the retailer.

“We are excited to launch our initial product from the Krillion and Rovion acquisitions. Local shopping content within a rich media ad unit provides us with a unique local display advertising product,” said Michael Sawtell, Local.com COO. “We believe this will prove to be valuable to a wide range of multi-channel retailers and consumer brands looking for higher performance results from their online advertising spend.”

“The Krillion integration represents another milestone in the evolution of Rovion’s RAMP technology. This highly effective offering will be made available to publishers, agencies, and brands within a platform that requires no technical proficiencies to create sophisticated rich media ad units,” said David Simon, vice president, Rovion. “We believe that this valuable new offering can provide additional monetization opportunities and significant new revenue growth to the markets we serve.”

According to Forrester Research nearly half of retail sales are “web-influenced,” and these web-influenced retail sales are expected to reach $1.2 trillion by the end of 2012.

About Local.com^®

Local.com Corporation (NASDAQ: LOCM), a leading online local media company, enables brick-and-mortar businesses to connect with online customers using a variety of digital marketing products. The company reaches more than 20 million consumers each month on the flagship Local.com website, 1,400 regional media sites and more than 100,000 geo-category websites. The company distributes daily deals via Spreebird.com, rich media ads via Rovion.com, and real-time product inventory information from more than 50,000 retailers nationwide via Krillion.com. To advertise, or for more information, visit: http://www.local.com/.

Forward Looking Statements

This press release contains forward looking statements that involve risks and uncertainties concerning Local.com Corporation’s expected financial performance, as well as Local.com’s strategic and operational plans. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, Yahoo!-Bing paying less RPC and revenues to us for our search results, our ability to adapt our business following the Yahoo!-Bing integration or to improve our RPCs and revenues following that integration, our ability to monetize the Local.com domain, including at a profit, our ability to retain a monetization partner for the Local.com domain and other web properties under our management that allows us to operate profitably, our ability to develop, market and operate our local-search technologies, our ability to market the Local.com domain as a destination for consumers seeking local-search results, our ability to grow our business by enhancing our local-search services, including through businesses we acquire, the future performance of our OCTANE360 business, the integration and future performance of our social buying business, our Krillion business and our Rovion business, as well as any other businesses we may acquire, our ability to successfully expand our Spreebird business into new markets, the possibility that the information and estimates used to predict anticipated revenues and expenses associated with the businesses we acquire are not accurate, difficulties executing integration strategies or achieving planned synergies, the possibility that integration costs and go-forward costs associated with the businesses we acquire will be higher than anticipated, our ability to successfully expand our sales channels for new and existing products and services, our ability to increase the number of businesses that purchase our advertising products, our ability to expand our advertiser and distribution networks, our ability to integrate and effectively utilize our acquisitions’ technologies, our ability to develop our products and sales, marketing, finance and administrative functions and successfully integrate our expanded infrastructure, as well as our dependence on major advertisers, competitive factors and pricing pressures, changes in legal and regulatory requirements, and general economic conditions. Any forward-looking statements reflect our current views with respect to future events and are subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this paragraph. Unless otherwise stated, all site traffic and usage statistics are from third-party service providers engaged by the company.

Our most recent Annual Report on Form 10-K/A, subsequent Quarterly Reports on Form 10-Q and Form 10-Q/A, recent Current Reports on Form 8-K and Form 8-K/A, and other Securities and Exchange Commission filings discuss the foregoing risks as well as other important risk factors that could contribute to such differences or otherwise affect our business, results of operations and financial condition. The forward-looking statements in this release speak only as of the date they are made. We undertake no obligation to revise or update publicly any forward-looking statement for any reason.

Media Relations Contact:

Local.com

Cameron Triebwasser

949-789-5223

ctriebwasser@local.com

Stein Mart, Inc. (SMRT) Announces Results of Annual Meeting

JACKSONVILLE, Fla., June 15, 2011 (GLOBE NEWSWIRE) — Stein Mart, Inc. (Nasdaq:SMRT) today announced the results of the 2011 annual meeting of shareholders and the authorization by the board of directors of the repurchase of an additional 2.5 million common shares.

Shareholders re-elected the twelve members of the board of directors for a one-year term. Shareholders also approved an advisory resolution on executive compensation; approved future advisory votes on executive compensation to occur annually; approved the material terms of the performance goals under the Stein Mart, Inc. 2011 Omnibus Plan and authorized three million additional shares available for issuance under that plan; and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered certified public accountants for the fiscal year ending January 28, 2012.

Re-elected for a one-year term were Jay Stein, chairman of the board, Stein Mart, Inc.; David H. Stovall, Jr., president and chief executive officer of Stein Mart, Inc.; Richard L. Sisisky, president of The Shircliff and Sisisky Company and lead director; Ralph Alexander, managing director of Riverstone Holdings LLC and former chief executive officer of Innovene; Alvin R. “Pete” Carpenter, former vice chairman of CSX Corporation; Irwin Cohen, senior advisor with the Peter J. Solomon Company and former global managing partner, retail and consumer products practice, Deloitte and Touche LLP; Susan Falk, chief executive officer of Betsey Johnson, LLC; Linda McFarland Farthing, former president and chief executive officer of Stein Mart, Inc.; Mitchell W. Legler, Esq., general counsel to the Company; Martin E. “Hap” Stein, Jr., chairman and chief executive officer of Regency Centers Corporation; Robert L. Mettler, former chairman and chief executive officer of Macy’s West; and John H. “Jack” Williams, Jr., vice chairman of the board and former chief executive officer of Stein Mart, Inc.

The additional authorization to repurchase 2.5 million shares increases the total share repurchase authorization to approximately 3.1 million shares.

About Stein Mart

Stein Mart stores offer the fashion merchandise, service and presentation of a better department or specialty store, at prices competitive with off-price retail chains. Currently with locations from California to Massachusetts, Stein Mart’s focused assortment of merchandise features current season, moderate to better fashion apparel for women and men, as well as accessories, shoes and home fashions.

The Stein Mart, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=9827

SMRT-G

Additional information about Stein Mart, Inc. can be found at www.steinmart.com

CONTACT: Nancy Murphy
         Director, Investor Relations
         (904) 346-1506
         nmurphy@steinmart.com

China GengSheng Minerals (CHGS) Awarded $4.2 Million Follow-on Fracture Proppants Contract

GONGYI, China, June 13, 2011 /PRNewswire-Asia-FirstCall/ — China GengSheng Minerals, Inc. (AMEX:CHGS – News), a leading China-based high-tech industrial materials manufacturer producing heat resistant, energy efficient materials for a variety of industrial applications, today announced that it has been awarded a $4.2 million follow-on fracture proppants supply contract from AMSAT International, a Florida-based technology company specializing in advanced ceramics. The Company will begin shipping fracture proppants under this new contract in July 2011, and expects to supply approximately 1,500 metric tons per month through December 2011, with specific quantities determined on a monthly basis, subject to available capacity.

This award follows the fulfillment of a $5.4 million contract with AMSAT International, under which GengSheng supplied approximately12,000 metric tons of proppant materials between January and June 2011.

“This represents our fourth supply contract with AMSAT, and we are proud that they continue to recognize GengSheng as a long-term, value-added partner and supplier of high quality proppant materials to their North American customers,” said Mr. Shunqing Zhang, Chairman and CEO of China GengSheng Minerals. “This latest order reinforces our belief in the sizeable growth opportunity for fracture proppants in the overseas markets, as we continue to build our brand, expand our sales channels, increase capacity and advance our products through continued technological development.”

Mr. Zhang continued, “We remain excited about the international opportunities for our proppants business, as export sales typically carry more favorable payment terms than our domestic contracts. We believe that the continued expansion of our overseas business will help reduce receivables and DSOs, while improving cash flow from operations and supporting our overall working capital needs as we grow the Company.”

Similar to the Company’s December 2010 order from AMSAT, this contract is for the supply of customized 69 MPa-sized proppant materials, which AMSAT will distribute to its North American customers in the oil and gas industry.

The Company launched its fracture proppant products in late 2007, and achieved revenue of $14.3 million in 2010, representing a three-year compound annual growth rate of 217%. In order to address growing domestic and international demand, GengSheng expanded manufacturing capacity to 90,000 metric tons in the first quarter of 2011, through a combination of in-house and OEM capacity. Additionally, the Company has begun construction on its second 60,000 metric ton fracture proppant manufacturing facility, which is expected to begin production in the third quarter of 2011. In 2011 to date, GengSheng has signed fracture proppant supply contracts totaling $20.1 million.

About China GengSheng Minerals, Inc.

China GengSheng Minerals, Inc. (“GengSheng”) develops, manufactures and markets a broad range of high-tech industrial material products, including monolithic refractories, industrial ceramics and fracture proppants. A market leader offering customized solutions, GengSheng sells its products primarily to the iron-and-steel industry as heat-resistant components for steel-making furnaces, industrial kilns and other high-temperature vessels to guarantee and improve the productivity of those expensive pieces of equipment while reducing their consumption of energy. Founded in 1986 and based in China‘s Henan province, GengSheng currently has over 200 customers in the iron, steel, oil, glass, cement, aluminum and chemical businesses located in China and other countries. GengSheng conducts business through GengSheng International Corporation, a British Virgin Islands company, and its Chinese subsidiaries, which are Henan GengSheng Refractories Co., Ltd., Zhengzhou Duesail Fracture Proppant Co., Ltd., Henan GengSheng Micronized Powder Materials Co., Ltd, Guizhou SouthEast Prefecture Co., Ltd., GengSheng New Materials Co., Ltd, and Henan GengSheng High Temperature Materials Co., Ltd.

For more information about the Company, please visit http://www.gengsheng.com.

To be added to the Company’s email distribution for future press releases, please send your request to gengsheng@tpg-ir.com.

Forward-looking Statement

This press release contains statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words “estimate,” “project,” “intend,” “forecast,” “anticipate,” “plan,” “planning,” “expect,” “believe,” “will,” “will likely, ” “should,” “could,” “would,” “may” or words or expressions of similar meaning. Such forward-looking statements are only predictions and are not guarantees of future performance. Investors are cautioned that any such forward-looking statements are and will be, as the case may be, subject to many risks, uncertainties, certain assumptions and factors relating to the operations and business environments of China GengSheng Minerals, Inc. and its subsidiaries that my cause the actual results of the companies to be materially different from any future results expressed or implied in such forward-looking statements. Although China GengSheng Minerals, Inc. believes that the expectations and assumptions reflected in the forward-looking statements are reasonable based on information currently available to its management, China GengSheng Minerals, Inc. cannot guarantee future results or events. China GengSheng Minerals, Inc. expressly disclaims a duty to update any of the forward-looking statement.

Argan, Inc. Reports First Quarter Results

Jun. 13, 2011 (Business Wire) — Argan, Inc. (NYSE AMEX: AGX) (Company) today announced financial results for the first quarter ended April 30, 2011 of its fiscal year 2012.

For the quarter ended April 30, 2011, net revenues were $16.0 million compared to $53.2 million during the quarter ended April 30, 2010. Gemma Power Systems (Gemma) contributed $14.0 million or 87.7% of net revenues from continuing operations in the first quarter of fiscal 2012, compared to $51.4 million, or 96.5% of net revenues from continuing operations in the first quarter of fiscal 2011. The reduction in net revenues was due primarily to the completion of the construction of a large gas fired power plant in Northern California in the first quarter. In May 2011, Gemma received full notice to proceed on a new 800 MW project near Desert Hot Springs, California.

The Company reported EBITDA (Earnings before interest, taxes, depreciation and amortization) from continuing operations of $1.4 million for the quarter ended April 30, 2011 compared to $4.0 million for the same prior year period. Gemma, for its segment, recorded $2.3 million in EBITDA for the first quarter of fiscal 2012 compared to $5.4 million in the first quarter of fiscal 2011.

During the quarter, Argan sold the assets of its wholly-owned subsidiary, Vitarich Laboratories, Inc., to NBTY, Florida, Inc. As a result, VLI is classified as a discontinued operation for financial reporting purposes. Argan realized a net loss on discontinued operations for the quarter of $139,000 compared to a net loss of $332,000 from discontinued operations in the same quarter in the preceding year.

In the first quarter of fiscal 2011, the Company reported income from continuing operations before income taxes of $1.2 million compared to income from continuing operations before income taxes of $3.7 million in the first quarter of 2011.

Net income for the quarter ended April 30, 2011 was $606,000, or $0.04 per diluted share based on 13,679,000 diluted shares outstanding, compared to net income of $2.0 million, or $0.15 per diluted share based on 13,790,000 diluted shares outstanding for the quarter ended April 30, 2010.

Argan had consolidated cash of $78.9 million as of April 30, 2011 and was debt free. Consolidated working capital increased during the current quarter to approximately $74.6 million as of April 30, 2011.

Gemma’s backlog as of April 30, 2011 was $293 million. Gemma received a full notice to proceed on the project to construct an 800 MW peaking plant energy facility in Southern California, which is included in our backlog with the value of $237 million at April 30, 2011.

Commenting on Argan’s results, Rainer Bosselmann, Chairman and Chief Executive Officer stated, “Our Gemma net revenues were soft during the first quarter, primarily due to the completion of the major power plant project in Northern California. Gemma was able to maintain its backlog of approximately $300 million and as the fiscal year progresses will show improved net revenues from the 800 MW peaking plant project which is in its initial phases of construction activity.”

Management uses EBITDA, a non-GAAP financial measure, for planning purposes, including the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management believes that EBITDA provides additional insight for analysts and investors in evaluating the Company’s financial and operational performance and in assisting investors in comparing the Company’s financial performance to those of other companies in the Company’s industry. However, EBITDA is not intended to be an alternative to financial measures prepared in accordance with GAAP and should not be considered in isolation from our GAAP results of operations from continuing operations. Pursuant to the requirements of SEC Regulation G, the reconciliation between the Company’s GAAP and non-GAAP financial results is provided above and investors are advised to carefully review and consider this information as well as the GAAP financial results that are disclosed in the Company’s SEC filings.

Note 1 – The condensed consolidated balance sheet as of January 31, 2011 has been derived from audited financial statements.

About Argan, Inc.

Argan’s primary business is designing and building energy plants through its Gemma Power Systems subsidiary. These energy plants include traditional gas as well as alternative energy including biodiesel, ethanol, and renewable energy sources such as wind power. Argan also owns Southern Maryland Cable, Inc.

Certain matters discussed in this press release may constitute forward-looking statements within the meaning of the federal securities laws and are subject to risks and uncertainties including, but not limited to: (1) the Company’s ability to achieve its business strategy while effectively managing costs and expenses; (2) the Company’s ability to successfully and profitably integrate acquisitions; and (3) the continued strong performance of the energy sector. Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in Argan’s filings with the Securities and Exchange Commission. In addition, reference is hereby made to cautionary statements with respect to risk factors set forth in the Company’s most recent reports on Form 10-K and 10-Q, and other SEC filings.

Argan, Inc.

Company Contact:

Rainer Bosselmann, 301-315-0027

or

Investor Relations Contact:

Arthur Trudel, 301-315-9467

The9 Limited (NCTY) Announces US$25 Million Share Repurchase Program

Pacific Ethanol, Inc. (PEIXD) Secures Increase in Kinergy’s Credit Facility to Support Strong Sales Growth

SACRAMENTO, Calif., June 13, 2011 (GLOBE NEWSWIRE) — Pacific Ethanol, Inc. (Nasdaq:PEIXD),the leading marketer and producer of low-carbon renewable fuels in the Western United States, announced that it has increased from $20 million to $30 million the credit facility of its subsidiary, Kinergy Marketing LLC with Wells Fargo Capital Finance, LLC. Subject to certain conditions, the credit facility has an accordion feature that provides the company with the ability to increase the facility to $35 million. The maturity date on the credit facility remains unchanged at December 31, 2013.

Neil Koehler, PEI’s president and CEO, stated, “Our total gallons sold have increased rapidly and consistently over the last seven quarters at an annualized compound growth rate of 66%. This growth continues as our unique distribution business enables us to increase our market share in the Western United States. Our expanded credit facility lowers our cost of capital and clearly demonstrates our lender’s confidence in our growth strategy.”

Additional terms and details of the credit facility are more particularly described in a Current Report on Form 8-K to be filed with the Securities and Exchange Commission today.

About Pacific Ethanol, Inc.

Pacific Ethanol, Inc. (Nasdaq:PEIXD) is the leading marketer and producer of low-carbon renewable fuels in the Western United States. Pacific Ethanol also sells co-products, including wet distillers grain (WDG), a nutritional animal feed. Serving integrated oil companies and gasoline marketers who blend ethanol into gasoline, Pacific Ethanol provides transportation, storage and delivery of ethanol through third-party service providers in the Western United States, primarily in California, Nevada, Arizona, Oregon, Colorado, Idaho and Washington. Pacific Ethanol has a 20% ownership interest in New PE Holdco LLC, the owner of four ethanol production facilities. Pacific Ethanol operates and manages the four ethanol production facilities, which have a combined annual production capacity of 200 million gallons. The facilities in operation are located in Boardman, Oregon, Burley, Idaho and Stockton, California, and one idled facility is located in Madera, California. The facilities are near their respective fuel and feed customers, offering significant timing, transportation cost and logistical advantages. Pacific Ethanol’s subsidiary, Kinergy Marketing LLC, markets ethanol from Pacific Ethanol’s managed plants and from other third-party production facilities, and another subsidiary, Pacific Ag. Products, LLC, markets WDG. For more information please visit www.pacificethanol.net.

The Pacific Ethanol, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5940

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

With the exception of historical information, the matters discussed in this press release including, without limitation, the ability of Pacific Ethanol to continue as the leading marketer and producer of low-carbon renewable fuels in the Western United States; the ability of Pacific Ethanol to effectively lower its cost of capital; and the ability of Kinergy to access and utilize the full amounts available under its credit facility, which is subject to various eligibility requirements and other limitations, are forward-looking statements and considerations that involve a number of risks and uncertainties. The actual future results of Pacific Ethanol could differ from those statements. Pacific Ethanol refers you to the “Risk Factors” section contained in its most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2011 and in its most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 13, 2011.

CONTACT: IR Agency Contact:
         Becky Herrick
         Lippert / Heilshorn & Assoc.
         415-433-3777
         Investorrelations@pacificethanol.net

         Company IR Contact
         Pacific Ethanol, Inc.
         916-403-2755
         866-508-4969

         Media Contact:
         Paul Koehler
         Pacific Ethanol, Inc.
         503-235-8241
         paulk@pacificethanol.net

Honeywell (HON) to Acquire EMS Technologies, Inc. (ELMG) for $491 Million

MORRIS TOWNSHIP, N.J., June 13, 2011 /PRNewswire/ — Honeywell (NYSE: HON) today announced that it has signed a definitive agreement to acquire EMS Technologies, Inc. (NASDAQ: ELMG), a leading provider of connectivity solutions for mobile networking, rugged mobile computers, and satellite communications, for $33 per share in cash, or an aggregate purchase price of approximately $491 million, net of cash acquired. The purchase price translates to approximately 13 times EMS’s 2010 earnings before interest, taxes, depreciation and amortization (EBITDA), or approximately 9 times 2010 EBITDA excluding certain corporate costs. The agreement provides for a subsidiary of Honeywell to commence a tender offer within 10 business days to purchase all outstanding shares of EMS.

The acquisition will enhance Honeywell’s existing capabilities in rugged mobile computing technologies and satellite communications within its Automation and Control Solutions (ACS) and Aerospace businesses. EMS’s $181 million Global Resource Management (GRM) division provides highly ruggedized mobile computing products and services for use in transportation, logistics, and workforce management settings as well as secure satellite-based asset tracking and messaging technology for search and rescue, warehousing, and field force automation environments. Through its $174 million Aviation division, EMS provides terminals, antennas, in-cabin network devices, rugged data storage, and surveillance applications predominantly for use on aircraft and in other data gathering objectives.

“EMS is a terrific addition to Honeywell, adding leading positions in attractive markets that are closely aligned with favorable trends in the growing Command, Control, Communications, Computers, Intelligence, Surveillance, and Reconnaissance (C4ISR) space and commercial aerospace, as well as being highly complementary to our existing Scanning and Mobility business,” said Honeywell Chairman and Chief Executive Officer Dave Cote. “Honeywell is uniquely positioned to acquire EMS due to the strategic fit across EMS’s Global Resource Management and Aviation divisions. The acquisition brings engineering expertise, differentiated technologies, global reach, and profitable adjacent segments that build upon our great positions in good industries and enhance our growth profile.”

EMS’s GRM division offers a broad range of solutions for supply chain logistics, mobile workforce management, and remote asset monitoring applications, supported by hundreds of partners worldwide. EMS’s proven mobile resource management solutions include LXE-branded rugged handheld and vehicle-mounted computers featuring multiple radio technologies and satellite-based global tracking and monitoring solutions for cargo, fleet assets, and personnel.

“This is another terrific transaction for our Scanning and Mobility business,” said Honeywell Automation and Control Solutions President and Chief Executive Officer Roger Fradin. “EMS strengthens our core mobile computing business and expands our addressable market with complementary new products, channel partners, and entry into the warehousing and port segments that we believe will be growth drivers for the business. This also represents an opportunity to demonstrate our proven acquisition integration process.”

EMS Aviation designs and manufactures satellite-based broadband communication systems that enable worldwide high-speed Internet and voice and video capabilities. The Aviation division serves a broad base of commercial and defense customers, delivering leading-edge antenna systems and beam-management capabilities for mobile network-centric operations, radar for battlefield visibility, and commercial aerospace connectivity.

“Combining EMS products into our Aerospace business means that Honeywell can now deliver the next big leap in satcom technology, a key growth area for aerospace,” said Honeywell Aerospace President and Chief Executive Officer Tim Mahoney. “Our customers will greatly benefit from these new products and solutions, enabling them to leverage the strong global growth of high-speed wireless and satellite data services.”

Honeywell has been informed that all directors and officers of EMS intend to tender all of their respective shares in the Offer. The Offer will be subject to the tender of a majority of EMS’s shares and customary closing conditions, including regulatory approvals. The transaction is expected to close in the third quarter of 2011. Although the transaction would be dilutive in 2011 by three to four cents, it is not expected to impact the company’s previously announced 2011 earnings per share guidance range, and Honeywell anticipates it to be accretive in 2012.

The tender offer described in this news release has not been commenced. This announcement and the description contained herein is neither an offer to purchase nor a solicitation of an offer to sell shares of EMS. At the time the tender offer is commenced, Honeywell and its wholly-owned subsidiary, Egret Acquisition Corp., intend to file a Tender Offer Statement on Schedule TO containing an offer to purchase, forms of letters of transmittal, and other documents relating to the tender offer and EMS intends to file a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the tender offer. Honeywell, Egret Acquisition Corp., and EMS intend to mail these documents to the stockholders of EMS. These documents will contain important information about the tender offer and stockholders of EMS are urged to read them carefully when they become available. Stockholders of EMS will be able to obtain a free copy of these documents (when they become available) and other documents filed by EMS, Honeywell, or Egret Acquisition Corp. with the SEC at the website maintained by the SEC at www.sec.gov. In addition, stockholders will be able to obtain a free copy of these documents (when they become available) from the information agent named in the offer to purchase or from Honeywell.

Honeywell (www.honeywell.com) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes, and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell’s shares are traded on the New York, London, and Chicago Stock Exchanges. For more news and information on Honeywell, please visit www.honeywellnow.com.

This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, that address activities, events or developments that we or our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements.

Leading Biotechnology Entrepreneur and Investor Isaac Blech (MDGN) Joins Medgenics Board of Directors

MISGAV, Israel & VIENNA, Va.–(BUSINESS WIRE)– Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) today announced that Isaac Blech, age 61, a leading biotechnology entrepreneur and investor, has joined the Company’s Board of Directors. Mr. Blech has served on the Company’s Strategic Advisory Board since February 2011 and is a major investor in the Company having invested over $7 million in the Company over the past year. The Medgenics Board of Directors now has seven members.

Mr. Blech is one of the most successful private financiers in the biotechnology industry. As an industry pioneer, he founded seven companies, all of which were subsequently brought public. These include Celgene Corporation, Genetic Systems Corporation, Icos Corporation, Nova Pharmaceuticals Corporation and PathoGenesis Corporation. These companies are responsible for major advances in a number of diseases including the diagnosis and/or treatment of cancer, chlamydia, sexual dysfunction, cystic fibrosis and AIDS. Their combined value is in excess of $30 billion.

Mr. Blech is a major shareholder and a Director of Socialwise, Inc., an innovator in e-commerce for the youth market, and is also a major shareholder and Director of ContraFect Corporation, a company developing therapies for infectious diseases, Mr. Blech is also a major shareholder of the public companies Premier Alliance Group, a financial consulting company, and Stratus Media Group, an owner, producer, promoter and operator of live entertainment events. Mr. Blech is also a founder, Director and major shareholder of Cerecor Inc., a private company developing new treatments for central nervous system disorders.

“It is with great pleasure that we welcome Isaac to our Board of Directors. Isaac’s in-depth experience in biotechnology commercialization and his impressive professional network should be instrumental in helping us build Medgenics into a leading biotechnology company pioneering personalized sustained therapy using our Biopump platform for continuous production and delivery of therapeutic proteins by the patient’s own skin. We look forward to Isaac’s active involvement and support as a Director, as we advance our platform technology toward commercialization in a number of chronic diseases,” stated Andrew L. Pearlman, Ph.D., President and CEO of Medgenics.

Commenting on his appointment, Isaac Blech said, “Medgenics is demonstrating its ability to use a patient’s own tissue to create Biopumps that, when inserted back into that patient, are designed to deliver sustained production of the desired protein. This is potentially a major scientific and medical breakthrough which has the ability to change the treatment paradigm across a range of chronic diseases. I am delighted to be working with the Medgenics team and look forward to guiding them in the successful clinical development and commercialization of this powerful technology.”

About Medgenics

Medgenics is developing and commercializing Biopump, a proprietary tissue-based platform technology for the sustained production and delivery of therapeutic proteins using the patient’s own skin biopsy for the treatment of a range of chronic diseases including anemia, hepatitis C and hemophilia. Medgenics believes this approach has multiple benefits compared with current treatments, which include regular and costly injections of therapeutic proteins.

Medgenics has three long-acting protein therapy products in development based on this technology:

• EPODURE (now completing a Phase I/II dose-ranging trial) to produce and deliver erythropoietin for many months from a single administration, has demonstrated elevation and stabilization of hemoglobin levels in anemic patients for 6 to more than 24 months;
• INFRADURE (to commence a Phase I/II trial in Israel in 2011) to produce a sustained therapeutic dose of interferon-alpha for use in the treatment hepatitis C;
• HEMODURE is a sustained Factor VIII therapy for the prophylactic treatment of hemophilia, now in development.

Medgenics intends to develop its innovative products and bring them to market via strategic partnerships with major pharmaceutical and/or medical device companies. Since October 2009, HEMODURE has been the focus of cooperation between Medgenics and a major healthcare company, a market leader in hemophilia.

In addition to treatments for anemia, hepatitis C and hemophilia, Medgenics plans to develop and/or out-license a pipeline of future Biopump products targeting the large and rapidly growing global protein therapy market, which is forecast to reach $132 billion in 2013. Other potential applications for Biopumps include multiple sclerosis, arthritis, pediatric growth hormone deficiency, obesity and diabetes.

Forward-looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995, which include all statements other than statements of historical fact, including (without limitation) those regarding the Company’s financial position, its development and business strategy, its product candidates and the plans and objectives of management for future operations. The Company intends that such forward-looking statements be subject to the safe harbors created by such laws. Forward-looking statements are sometimes identified by their use of the terms and phrases such as “estimate,” “project,” “intend,” “forecast,” “anticipate,” “plan,” “planning, “expect,” “believe,” “will,” “will likely,” “should,” “could,” “would,” “may” or the negative of such terms and other comparable terminology. All such forward-looking statements are based on current expectations and are subject to risks and uncertainties. Should any of these risks or uncertainties materialize, or should any of the Company’s assumptions prove incorrect, actual results may differ materially from those included within these forward-looking statements. Accordingly, no undue reliance should be placed on these forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, the events described in the forward-looking statements contained in this release may not occur.

Lockwood Broadcast Group Signs Long Term Contract With Rentrak (RENT) for Sherman, Texas Television Stations

PORTLAND, Ore., June 8, 2011 /PRNewswire/ — Rentrak Corporation (NASDAQ:RENT – News), the leader in multi-screen media measurement serving the advertising, television and entertainment industries, today announced a multi-year StationView Essentials contract to provide local market TV ratings data for three Lockwood Broadcast Group television stations located in Sherman, Texas.

“Rentrak’s massive database of passively measured audience data, providing 24/7/365 electronic measurement of real viewer behaviors, is exactly what local broadcasters have been seeking for years,” said Dave Hanna, President of Lockwood Broadcast Group. “Stations even in small markets like Sherman are finally able to be confident in the accuracy and stability of the audience information we use to value and sell our inventory in the marketplace every day.”

“Rentrak leads the industry in quantitative and behavioral audience measurement innovation with the StationView Essentials system, which provides household-based demographics as a feature of the basic offering to broadcasters and agencies as well as critical consumer purchase data integrated into ‘third- party processor’ systems,” said Steven Walsh, Rentrak’s Senior Vice President of Local Television Sales. “We look forward to a long and mutually successful partnership with Lockwood Broadcast Group.”

Available in all 210 television markets, Rentrak’s StationView Essentials service features the only fully-integrated database of detailed satellite, telco TV and cable viewing information from over 18 million televisions nationwide. Providing uniform measurement 365 days a year across every zip code in the United States, StationView Essential combines database integration of viewing habits with product consumption information in order to generate relevant “purchaser ratings” for its clients.

About Rentrak Corporation

Rentrak (NASDAQ:RENT – News) is a global digital media measurement and research company, serving the most recognizable companies in the entertainment industry. With a reach across numerous platforms including box office, multi-screen television and home video, Rentrak has developed more efficient metrics to be used as database currencies for the evaluation and selling of media. Rentrak is headquartered in Portland, Oregon, with additional U.S. and international offices. For more information on Rentrak, please visit www.rentrak.com.

Pharmasset (VRUS) Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C

PRINCETON, N.J., June 8, 2011 /PRNewswire/ — Pharmasset, Inc. (Nasdaq:VRUS – News) announced today the addition of three treatment cohorts to the ELECTRON trial of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The rapid and consistent antiviral effects and high barrier to resistance demonstrated with PSI-7977 to date provide the rationale for additional exploratory regimens in this setting. This amendment will add one arm exploring 12 weeks of PSI-7977 monotherapy (without peginterferon and ribavirin) and two arms of interferon-sparing therapy: one for 8 weeks of PSI-7977 plus peginterferon and ribavirin (Peg-IFN/RBV) in patients with HCV genotype 2 (GT2) or 3 (GT3) and one for 12 weeks of PSI-7977 plus Peg-IFN/RBV in patients with HCV genotype 1 (GT1) prior null responses.

“The combination data reported at EASL demonstrated that SVRs were achievable with two oral DAAs in the absence of peginterferon and ribavirin,” stated Bill Symonds, PharmD, Pharmasset’s Senior Vice President of Clinical Pharmacology and Translational Medicine, “We continue to explore the potential for removing peginterferon and ribavirin from the HCV treatment regimen. Given the encouraging data we are seeing in ELECTRON, we have decided to expand the study to investigate PSI-7977 monotherapy, as well as shorter treatment regimens based on the promising data we reported at EASL from PROTON.”

Pharmasset anticipates reporting results from the first four arms of the trial (n=40) during the second half of 2011. We have submitted a number of abstracts to the 2011 American Association for the Study of Liver Diseases (AASLD) meeting, including data from the ELECTRON and PROTON trials.

About the Trial

The ELECTRON trial is an exploratory study of PSI-7977 for the treatment of chronic HCV infection. Part 1 of the trial is evaluating 12-week regimens of PSI-7977 400mg QD in combination with ribavirin (RBV) only, and in separate arms with abbreviated durations of Peg-IFN for 4, 8, or 12 weeks in treatment-naive patients with HCV GT2 or GT3. The primary endpoint of the trial is the safety and tolerability of PSI-7977 400mg QD and RBV for 12 weeks, administered with or without Peg-IFN. On May 11, 2011, Pharmasset announced the completed enrollment of Part 1 of ELECTRON in patients with HCV GT 2 or GT 3:

• PSI-7977 400mg with RBV for 12 weeks (no peginterferon);
• PSI-7977 400mg with RBV for 12 weeks; Peg-IFN weeks 1-4 only;
• PSI-7977 400mg with RBV for 12 weeks, Peg-IFN weeks 1-8 only;
• PSI-7977 400mg with Peg-IFN and RBV for 12 weeks.

In Part 2 of ELECTRON, Pharmasset will enroll an additional 30 patients into exploratory regimens of monotherapy and abbreviated durations of total therapy. Following on the first four Cohorts of ELECTRON a 5th cohort will be added to explore 7977 400mg monotherapy in treatment-naive patients with HCV GT2 or GT3:

• PSI-7977 400mg monotherapy for 12 weeks.

With the previously reported 100% SVR12 in naive GT2/3 subjects in PROTON, a 6th and 7th cohort will be added to ELECTRON to explore shorter treatment durations in both GT2/3 naive subjects and HCV GT1 subjects who have documented null responses (less than 2 log(10) IU/mL reduction in HCV RNA after 12 weeks of Peg-IFN/RBV):

• PSI-7977 400mg with Peg-IFN/RBV for 8 weeks
• PSI-7977 400mg QD with Peg-IFN/RBV for 12 weeks.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset’s primary focus is the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. Our research and development efforts are focused on nucleoside/tide analogs, a class of compounds which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. We currently have three clinical-stage product candidates advancing in trials in various populations. Our pyrimidine, PSI-7977, an unpartnered uracil nucleotide analog, is currently under study in three Phase 2b trials in patients with HCV genotypes 1 through 6, including abbreviated duration interferon and interferon-free regimens. Our purine, PSI-938, an unpartnered guanosine nucleotide analog, recently reported safety and efficacy data from 14 days of monotherapy as well as 14 days in combination with the pyrimidine, PSI-7977. An SVR-endpoint study of the purine-pyrimidine combination is anticipated to begin in the third quarter of 2011. Mericitabine (RG7128) continues in two Phase 2b trials and one interferon-free trial being conducted through a strategic collaboration with Roche.

Contact
Richard E. T. Smith, Ph.D.
VP, Investor Relations and Corporate Communications
Office: +1 (609) 865-0693

Forward-Looking Statements

Pharmasset “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release that are not historical facts are “forward-looking statements,” that involve risks, uncertainties, and other important factors, including, without limitation, the risk of cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful, and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of risks, uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2010 and our Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission and discussions of potential risks, uncertainties, and other important factors in our subsequent filings with the Securities and Exchange Commission.